Please wait while the formulary information is being retrieved.
CLEOCIN T (CLINDAMYCIN PHOSPHATE)
- Acne vulgaris
- Clindamycin Topical Solution
- Clindamycin Topical Gel
- Clindamycin Phosphate Topical Solution
- Clindamycin Lotion
- Cleocin T Topical Gel
- Cleocin T Solution
- Cleocin T Lotion
- By Indication
1 % topical solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
clindamycin 1 % topical gel
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
clindamycin 1 % lotion
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % topical gel
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % solution
- Apply a thin layer to the affected area(s) by topical route 2 times per day
1 % lotion
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Acne rosacea
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Acne vulgaris
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- Crohn's disease
- Ulcerative colitis
Contraindicated
- Clostridium difficile infection
Severe
Moderate
- Atopic dermatitis
CLEOCIN T (CLINDAMYCIN PHOSPHATE)
- Acne vulgaris
- Erythema
- Pruritus of skin
- Abnormal desquamation
- Dry skin
- Skin irritation
More Frequent
Severe
Less Severe
- Skin rash
- Urticaria
- Headache disorder
- Oily skin
- Stinging of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bloody diarrhea
- Clostridium difficile infection
Less Severe
- Acute abdominal pain
- Contact dermatitis
- Diarrhea
- Gram-negative folliculitis
- Ocular pain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Clindamycin (Topical)
Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Clindamycin (top, Vag)
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Clindamycin (top, Vag)
Avoiding nipple area application will reduce infants risk for diarrhea
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Avoiding nipple area application will reduce infants risk for diarrhea |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
Formulary Reference Tool